In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype
暂无分享,去创建一个
M. D. Boer | R. Pieters | A. Veerman | J. Harbott | O. Haas | O. Haas | W. Ludwig | H. Beverloo | G. Janka-Schaub | G. Janka‐Schaub | E. V. Wering | A. Veerman | A. Loonen | R. Slater | W. Ludwig | A. Loonen | B. Camitta | N. R. Woerden | B. Camitta | ML den Boer | NL Ramakers-van Woerden
[1] C. Pui,et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region , 2002, The Lancet.
[2] C. Pui,et al. Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance , 2002, Leukemia.
[3] C. Pui,et al. Biological and therapeutic aspects of infant leukemia. , 2000, Blood.
[4] E. Shacter,et al. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. , 2000, Blood.
[5] P. Sonneveld,et al. The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia. , 2000, International journal of clinical pharmacology and therapeutics.
[6] H. Beverloo,et al. Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set , 1999, Leukemia.
[7] A. Borkhardt,et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. , 1999, Blood.
[8] D. Arthur,et al. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) – a report of the Children’s Cancer Group , 1999, Leukemia.
[9] N. Heerema,et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] G. Peters,et al. Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT Assay , 1999 .
[11] M. D. Boer,et al. Mechanisms of cellular anthracycline resistance in childhood acute leukemia , 1998, Leukemia.
[12] D. Wang,et al. Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis , 1998, Leukemia.
[13] E. Thiel,et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. , 1998, Blood.
[14] M. D. Boer,et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants , 1998, Leukemia.
[15] J. V. van Dongen,et al. Intensified therapy for infants with acute lymphoblastic leukemia , 1998 .
[16] R. Pieters,et al. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. , 1998, Blood.
[17] A. Borkhardt,et al. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. , 1997, Blood.
[18] R. Gelber,et al. Intensified therapy for infants with acute lymphoblastic leukemia , 1997, Cancer.
[19] M. D. Boer,et al. Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia , 1997, Leukemia.
[20] T. Hongo,et al. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. , 1997, Blood.
[21] M. Greaves. Infant leukaemia biology, aetiology and treatment. , 1996, Leukemia.
[22] F. Behm,et al. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. , 1996, The Journal of clinical investigation.
[23] N. Heerema,et al. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23). , 1995, Blood.
[24] C. Mecucci,et al. Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies. , 1995, Leukemia.
[25] H. Clevers,et al. The drug resistance-related protein LRP is the human major vault protein , 1995, Nature Medicine.
[26] R. Pieters,et al. Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. , 1994, British Journal of Cancer.
[27] G. Basso,et al. The role of immunophenotype in acute lymphoblastic leukemia of infant age. , 1994, Leukemia & lymphoma.
[28] J. Shuster,et al. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1994, Blood.
[29] R. Pieters,et al. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. , 1994, Leukemia.
[30] M. Slovak,et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.
[31] R. Pieters,et al. In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. , 1991, British Journal of Cancer.
[32] R. Pieters,et al. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia , 1991, The Lancet.
[33] R. Pieters,et al. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. , 1988, Cancer letters.
[34] P Berg,et al. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.
[35] M. Graham,et al. A Preliminary Report , 1953 .
[36] R. Pieters,et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. , 1997, Blood.
[37] F. Behm,et al. 11q23 rearrangements in acute leukemia. , 1996, Leukemia.
[38] A. Borkhardt,et al. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. , 1995, Leukemia.
[39] J. Wiegant,et al. Detection of the Philadelphia chromosome in interphase nuclei. , 1990, Cytogenetics and cell genetics.
[40] R. Pieters,et al. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. , 1990, Blood.